Medicare Enrolled
Dr. Roy Avalos, M.D.
Cardiovascular Disease · Encinitas, CA
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Avalos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Avalos?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Avalos
Dr. Roy Avalos is a cardiovascular disease specialist in Encinitas, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Avalos performed 3,922 Medicare services across 2,747 unique beneficiaries.
Between the years covered by Open Payments, Dr. Avalos received a total of $16,762 from 59 pharmaceutical and/or device companies across 636 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Avalos is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 27% volume in CA
$16,762 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,922
Medicare services
Top 27% in CA for cardiovascular disease
2,747
Unique beneficiaries
$114
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~196 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
526 | $76 | $600 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
492 | $42 | $204 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
467 | $137 | $308 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
335 | $98 | $216 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
275 | $54 | $154 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
269 | $169 | $455 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
268 | $390 | $1,058 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
255 | $97 | $230 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
169 | $141 | $419 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
167 | $10 | $25 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
70 | $10 | $113 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
63 | $408 | $1,201 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
62 | $3 | $8 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
50 | $11 | $30 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
48 | $6 | $31 |
| Cardiac catheterization | 46 | $165 | $606 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
41 | $85 | $235 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
30 | $20 | $59 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
29 | $10 | $26 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
29 | $20 | $43 |
| Coronary angiography A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels. |
27 | $107 | $491 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
26 | $766 | $1,583 |
| Drug infusion during cardiac catheterization Administration of medication through a catheter inserted into the heart during a cardiac catheterization procedure. |
26 | $79 | $206 |
| New patient office visit, complex (60-74 min) | 25 | $175 | $435 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
24 | $12 | $36 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
22 | $19 | $55 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
17 | $25 | $78 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
17 | $89 | $230 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
17 | $12 | $33 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
16 | $51 | $108 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
14 | $74 | $194 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.9% high complexity
45.7% medium
42.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,762
Total received (2018-2024)
Avg $2,395/year across 7 years
Top 20% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
636
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,741 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,161
2023
$2,789
2022
$3,204
2021
$936
2020
$737
2019
$3,600
2018
$2,335
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Inari Medical, Inc.
$419
Penumbra, Inc.
$307
Amgen Inc.
$289
Medtronic, Inc.
$203
Merck Sharp & Dohme LLC
$184
Novo Nordisk Inc
$162
Novartis Pharmaceuticals Corporation
$157
HEARTFLOW, INC.
$154
AstraZeneca Pharmaceuticals LP
$147
Esperion Therapeutics, Inc.
$141
iRhythm Technologies, Inc.
$120
PFIZER INC.
$114
Kestra Medical Technology Services, Inc.
$112
ABIOMED
$104
CVRx, Inc.
$81
E.R. Squibb & Sons, L.L.C.
$74
Actelion Pharmaceuticals US, Inc.
$73
Lexicon Pharmaceuticals, Inc.
$73
SANOFI-AVENTIS U.S. LLC
$60
Kiniksa Pharmaceuticals International, plc
$45
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$44
Janssen Pharmaceuticals, Inc
$44
Abbott Laboratories
$31
Boston Scientific Corporation
$22
Top 3 companies account for 32.1% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$1,600
PFIZER INC.
$1,237
Amgen Inc.
$1,020
Novartis Pharmaceuticals Corporation
$1,019
SANOFI-AVENTIS U.S. LLC
$897
AstraZeneca Pharmaceuticals LP
$896
Merck Sharp & Dohme LLC
$876
Abbott Laboratories
$724
Esperion Therapeutics, Inc.
$684
E.R. Squibb & Sons, L.L.C.
$623
Janssen Pharmaceuticals, Inc
$580
Medtronic, Inc.
$470
Boehringer Ingelheim Pharmaceuticals, Inc.
$463
Actelion Pharmaceuticals US, Inc.
$448
ABIOMED
$439
Inari Medical, Inc.
$437
CVRx, Inc.
$417
Penumbra, Inc.
$307
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$297
iRhythm Technologies, Inc.
$293
Gilead Sciences, Inc.
$276
Medtronic Vascular, Inc.
$243
Regeneron Healthcare Solutions, Inc.
$200
Novo Nordisk Inc
$196
Amarin Pharma Inc.
$159
Shockwave Medical, Inc
$156
HEARTFLOW, INC.
$154
Kestra Medical Technology Services, Inc.
$143
Biosense Webster, Inc.
$135
Chiesi USA, Inc.
$135
Kiniksa Pharmaceuticals, Ltd.
$123
HeartFlow, Inc.
$89
Kowa Pharmaceuticals America, Inc.
$82
Allergan Inc.
$78
Lexicon Pharmaceuticals, Inc.
$73
Lundbeck LLC
$72
Merck Sharp & Dohme Corporation
$71
BOSTON SCIENTIFIC CORPORATION
$70
Edwards Lifesciences Corporation
$66
Bardy Diagnostics, Inc.
$61
Impulse Dynamics (USA) Inc.
$50
Otsuka America Pharmaceutical, Inc.
$45
Kiniksa Pharmaceuticals International, plc
$45
Alnylam Pharmaceuticals Inc.
$40
BIOTRONIK INC.
$24
Teleflex LLC
$22
Cardiovascular Systems Inc.
$22
AtriCure, Inc.
$21
SCPHARMACEUTICALS INC.
$20
Philips Electronics North America Corporation
$19
Akcea Therapeutics, Inc.
$19
AngioDynamics, Inc.
$18
Arrow Interventional, Inc.
$17
Astellas Pharma US Inc
$17
G Medical Diagnostic Services, Inc.
$16
Lilly USA, LLC
$15
PORTOLA PHARMACEUTICALS, INC.
$14
Itamar Medical Inc
$14
Tactile Systems Technology Inc
$13
Top 3 companies account for 23.0% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · AMPLATZER AMULET · AMVUTTRA · ANDEXXA · Allure CRT Pacemaker · Arcalyst · Asahi Fielder coronary guide wire · Assure WCD · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CARTO 3 · CHANTIX · Cardiac Monitoring Suite · CardioMEMS HF System · Carnation Ambulatory Monitor · Catheter - GuideLiner · Confirm Rx · Corlanor · Coronary Orbital Atherectomy System · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · Ellipse ICD · FARXIGA · FFRct · FLEXITOUCH · FLOWTRIEVER CATHETER · FUROSCIX · Fortify Assura · GENERAL THERAPIES · General - Tachy · General - Vascular Access · HeartMate · Impella · Indigo System · Inpefa · JARDIANCE · KENGREAL · LATITUDE · LEQVIO · LEXISCAN · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MITRACLIP · MULTAQ · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · ONYX FRONTIER · OPSUMIT · OPSUMIT MACITENTAN · Optimizer · Orsiro Mission · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · Reveal LINQ · S · SAMSCA · SAPIEN 3 Ultra RESILIA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · TEGSEDI · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRULICITY · TURNPIKE · TYRX · UPTRAVI · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · VenaCure 1470 Pro · VenaSeal · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WatchPAT · XARELTO · ZIO Patch · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
224
Per 100K population
6.8
County median income
$102,285
Nearest hospital
SCRIPPS MEMORIAL HOSPITAL - ENCINITAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Avalos is a cardiac imaging specialist, with above-average Medicare volume (top 27% in CA), with low-engagement industry engagement in the top 20% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Avalos experienced with technetium tc-99m tetrofosmin diagnostic injection?
Based on Medicare claims data, Dr. Avalos performed 526 technetium tc-99m tetrofosmin diagnostic injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Avalos receive payments from pharmaceutical companies?
Yes. Dr. Avalos received a total of $16,762 from 59 companies across 636 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Avalos's costs compare to other cardiologists in Encinitas?
Dr. Avalos's average Medicare payment per service is $114. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Avalos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Encinitas
Browse cardiologists in Encinitas ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology